Dr. Payam Tristani-firouzi, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W Ste 111, Provo, UT 84604 Phone: 801-374-8999 Fax: 801-429-8063 |
Dr. Richard L Stone, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1275 N University Ave Ste 23, Provo, UT 84604 Phone: 801-377-4745 Fax: 801-373-5762 |
Garrett C Lowe, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3200 N Canyon Rd Ste D, Provo, UT 84604 Phone: 801-373-3300 Fax: 801-354-7900 |
Mr. Gregory J Wing, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W Ste 111, Provo, UT 84604 Phone: 801-354-8225 Fax: 801-418-0941 |
Margaret Hammond, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 395 W Cougar Blvd Ste 604, Provo, UT 84604 Phone: 801-357-0613 |
Brian R Bradshaw, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 111, Provo, UT 84604 Phone: 801-374-8999 Fax: 801-429-8063 |
Dr. Richard W Parkinson, M.D. Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 5314 N 250 W, Suite 220, Provo, UT 84604 Phone: 801-225-8484 Fax: 801-225-6170 |
Mark L Donaldson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 111, Provo, UT 84604 Phone: 801-374-8999 Fax: 801-429-8063 |
News Archive
In a study being presented today at the annual meeting of the Radiological Society of North America (RSNA), researchers say they may have an explanation as to why African Americans, despite having lower amounts of coronary artery calcification, are at increased risk for heart attacks and other cardiovascular events compared with Caucasians.
A survey conducted in primary care practices showed that a small proportion of women are eligible for discussions about use of tamoxifen to prevent cancer, and of those women, the proportion of breast cancers that would be prevented is also small
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study demonstrated that its single-use autologous cell suspension technology ReCell was safe and effective in skin repigmentation for patients suffering with depigmented skin lesions caused by vitiligo and piebaldism.
Helmholtz Zentrum M-nchen has launched a new cooperative project with SIRION BIOTECH GmbH in Martinsried to develop new therapeutic approaches against lymphoid tumors. With a two-year grant from the Federal Ministry for Economics and Technology, the two partners will seek to further develop lentiviral vector systems to better understand the disease mechanisms of this cancer form and to devise approaches for treatment.
Researchers have shown that the subsequent 2 to 3 years after discharge from the hospital following treatment for pneumonia may provide only a short-term lease on a future healthy life if the patient has certain significant and independent predictors of mortality.
› Verified 5 days ago